Sale!

CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

Living with unexplained nocturnal seizures can be frightening and isolating. Our CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 NGS Genetic DNA Test provides the answers you’ve been searching for. For just ZAR 6,700 (regularly ZAR 9,350), this comprehensive test uses advanced Next Generation Sequencing technology to detect mutations in the CHRNA4 gene that cause nocturnal frontal lobe epilepsy. We understand the anxiety that comes with unexplained nighttime episodes, and our test delivers the clarity needed for proper diagnosis and treatment planning. With results in 3-4 weeks and nationwide coverage including Johannesburg, Cape Town, and Durban, you can trust Oracle Genomics for accurate, reliable genetic testing backed by neurological expertise. Take control of your health journey today with confidence and peace of mind.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

CHRNA4 Epilepsy DNA Test | ZAR 6
CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Find Answers for Nocturnal Seizures with CHRNA4 Genetic Testing

Waking up to unexplained nighttime episodes can leave you feeling confused, frightened, and searching for answers. If you or a loved one experiences sudden movements, strange sensations, or unusual behaviours during sleep, our CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 test provides the clarity you need. We understand the emotional toll of living with undiagnosed nocturnal seizures, and we’re here to help you find the answers that lead to proper management and peace of mind.

Understanding Your CHRNA4 Epilepsy Test

This specialised genetic test examines the CHRNA4 gene using advanced Next Generation Sequencing (NGS) technology to identify mutations that cause nocturnal frontal lobe epilepsy type 1. Unlike standard epilepsy tests, our analysis specifically targets the genetic root of your nighttime symptoms, providing precise information that helps your neurologist develop the most effective treatment plan for your unique condition.

Who Should Consider This Test?

This test is particularly important if you experience:

  • Sudden awakenings with unusual movements or behaviours
  • Strange sensations or feelings during sleep
  • Family history of nocturnal seizures or epilepsy
  • Unexplained nighttime episodes that disrupt sleep
  • Previous inconclusive epilepsy test results
  • Symptoms that predominantly occur during sleep

Many South Africans with these symptoms have found life-changing answers through genetic testing, enabling them to finally understand and manage their condition effectively.

Why This Test Matters for Your Health

Early and accurate diagnosis of CHRNA4-related epilepsy can transform your quality of life. By identifying the specific genetic cause of your nocturnal seizures, you gain:

  • Personalised Treatment: Targeted medication plans that address your specific genetic profile
  • Family Planning Insights: Understanding inheritance patterns for future generations
  • Reduced Anxiety: Clarity about your condition and what to expect
  • Improved Sleep Quality: Better management leading to more restful nights
  • Peace of Mind: Knowing the exact nature of your condition

Understanding Your Test Results

We know waiting for genetic test results can be anxiety-provoking. Our comprehensive reporting includes:

  • Clear explanation of your CHRNA4 gene analysis
  • Detailed interpretation of findings in understandable language
  • Guidance on next steps and treatment options
  • Genetic counselling support to help you understand the implications
  • Connection to neurological specialists if needed

Your results will be delivered within 3-4 weeks, and our team is available to answer any questions you may have about your report.

Transparent Pricing – Exceptional Value

Test Option Regular Price Special Price Savings
CHRNA4 Epilepsy Genetic Test ZAR 9,350 ZAR 6,700 ZAR 2,650

Includes genetic counselling session and comprehensive result interpretation

Why Trust Oracle Genomics?

As South Africa’s leading genetic testing provider, we offer:

  • Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Neurological Expertise: Tests reviewed by specialist neurologists
  • Advanced Technology: State-of-the-art NGS sequencing for maximum accuracy
  • Genetic Counselling: Professional support throughout your testing journey
  • Proven Accuracy: Reliable results you can trust for important health decisions

Simple Testing Process

Getting tested is straightforward and convenient:

  • Sample Collection: Blood sample or simple finger-prick blood spot on FTA card
  • Preparation: Clinical history review and genetic counselling session
  • Family History: We’ll help create a pedigree chart of affected family members
  • Convenient Locations: Testing centres across major South African cities

Take the First Step Toward Clarity Today

Don’t let unexplained nocturnal episodes control your life any longer. With our special pricing of ZAR 6,700, now is the perfect time to get the answers you deserve. Early detection leads to better management and improved quality of life.

Book Your Test Now

  • Online Booking: Secure online appointment scheduling
  • Phone Consultation: Speak with our genetic counsellors
  • Clinic Visit: Visit our centres in Johannesburg, Cape Town, or Durban
  • Home Collection: Mobile sample collection service available

Limited Time Offer: This special pricing of ZAR 6,700 won’t last forever. Take action today to secure your peace of mind and begin your journey toward better health management.

Call now or book online to schedule your genetic counselling session and take control of your nocturnal epilepsy diagnosis.